Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Panobinostat in Neuroendocrine Tumors
NCT00985946Phase 2Terminated
- Sponsor
- University of Wisconsin–Madison
- Start
- May 2010
- Primary completion
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of panobinostat in Neuroendocrine Neoplasm (NEN), sponsored by University of Wisconsin–Madison. Started May 2010; status: terminated.
02
Drugs
panobinostat
03
Conditions
Neuroendocrine Neoplasm (NEN)
Beyond the preview
Go deeper on NCT00985946.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00985946.